ADMINISTRATION OF KARENITECIN FOR THE TREATMENT OF ADVANCED OVARIAN CANCER, INCLUDING CHEMOTHERAPY-RESISTANT AND/OR THE MUCINOUS ADENOCARCINOMA SUB-TYPES - Patent 3033150

(19)

(11)

EP 3 033 150 A1

(12)

(43)	Date of publication:
	22.06.2016 Bulletin 2016/25

(21)	Application number: 14836702.2

(22)	Date of filing: 10.08.2014

(51)

International Patent Classification (IPC):

A61P 35/00^(2006.01)

(86)	International application number:
	PCT/US2014/050463

(87)	International publication number:
	WO 2015/023551 (19.02.2015 Gazette 2015/07)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME

(30)

Priority:

13.08.2013 US 201361865360 P

(71)	Applicant: BIONUMERIK PHARMACEUTICALS, INC.
	San Antonio, Texas 78229 (US)

(72)	Inventor:
	HAUSHEER, Frederick H. Fair Oaks Ranch, TX 78015 (US)

(74)	Representative: Lucas, Phillip Brian
	Lucas & Co. 135 Westhall Road Warlingham, Surrey CR6 9HJ Warlingham, Surrey CR6 9HJ (GB)

(54)	ADMINISTRATION OF KARENITECIN FOR THE TREATMENT OF ADVANCED OVARIAN CANCER, INCLUDING CHEMOTHERAPY-RESISTANT AND/OR THE MUCINOUS ADENOCARCINOMA SUB-TYPES